Partnership Opportunities Foundation Medicine has a history of forming partnerships with other biotech companies, such as Repare Therapeutics. This presents sales professionals with opportunities to collaborate and offer genomic profiling services to support clinical trials and develop companion diagnostics.

Expansion through Collaborations Recent collaborations with companies like Pierre Fabre Laboratories showcase Foundation Medicine's expansion into developing companion diagnostics for targeted therapies. Sales teams can explore partnerships to offer FoundationOne CDx and FoundationOneLiquid CDx genomic tests to treat specific patient groups.

Executive Leadership Change The appointment of Robert G. Xuereb and Dan Malarek as Chief Executive Officers signifies potential shifts in strategy and direction at Foundation Medicine. Sales representatives can leverage these leadership changes to align their sales pitches with the company's new vision and goals.

Market Expansion Plans Foundation Medicine's focus on developing companion diagnostics for Non-Small Cell Lung Cancer (NSCLC) indicates a strategic move towards expanding its market presence in targeted therapy segments. Sales professionals can tap into this niche by offering personalized genomic solutions to cater to NSCLC patients.

Competitive Edge in Genomic Profiling With a comprehensive suite of genomic profiling assays, Foundation Medicine stands out in the biotechnology research industry. Sales development representatives can emphasize the unmatched precision and depth of genomic insights offered by Foundation Medicine to differentiate and attract potential customers.